SCHW
65
-2
PNR
74
5
WDC
38
-3
PDCO
30
-6
DOV
73
4
URBN
66
2
XEL
65
-2
NRG
50
-2
EFX
41
-2
STX
52
-4
NOC
40
-10
QCOM
55
-2
OI
43
-2
DGX
48
-3
FTI
78
-3
DVN
29
4
LEN
52
2
MMM
42
5
KHC
17
4
SIG
47
-2
SCHW
65
-2
PNR
74
5
WDC
38
-3
PDCO
30
-6
DOV
73
4
URBN
66
2
XEL
65
-2
NRG
50
-2
EFX
41
-2
STX
52
-4
NOC
40
-10
QCOM
55
-2
OI
43
-2
DGX
48
-3
FTI
78
-3
DVN
29
4
LEN
52
2
MMM
42
5
KHC
17
4
SIG
47
-2
Financhill
Back

Cryo-Cell International 10K Form

Buy
90

CCEL
Cryo-Cell International

Last Price:
8.83
Seasonality Move:
5.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CCEL News And Ratings

See the #1 stock for the next 7 days that we like better than CCEL

CCEL Financial Statistics

Sales & Book Value

Annual Sales: $31.34M
Cash Flow: $2.12M
Price / Cash Flow: 43.8
Annual Sales: $-1.19
Price / Book: 0

Profitability

EPS (TTM): -1.07300
Net Income (TTM): $-8.93M
Gross Margin: $22.9M
Return on Equity: 0%
Return on Assets: -14.03%

Cryo-Cell International Earnings Forecast

Key Cryo-Cell International Financial Ratios

  • The Gross Profit Margin over the past 28 years for CCEL is 73.07%.
  • The Selling, General & Administrative Expenses for CCEL have been equal to 54.61% of Gross Profit Margin.
  • The Research & Development expenses have been 3.74% of Revenue.
  • The Interest Expense is -12.99% of Operating Income.
  • The Net Earning history of CCEL is -30.38% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 13 years.

Cryo-Cell International Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: CCEL
Website: cryo-cell.com

Debt

Debt-to-Equity Ratio: -1.12
Current Ratio: 0.61
Quick Ratio: 0.52

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 77.75

CCEL Technical Analysis vs Fundamental Analysis

Buy
90
Cryo-Cell International (CCEL) is a Buy

Is Cryo-Cell International a Buy or a Sell?